Spinal Fusion Surgery in India and UAE | Complete Patient Guide

ELIGIBLE CANDIDATES (Indications for Surgical Referral):

• Degenerative disc disease (DDD) at one or more levels with concordant axial pain confirmed on MRI and provocative discography, refractory to ≥6 months of conservative management

• Lumbar or cervical spondylolisthesis (Grade I–IV on Meyerding classification) causing mechanical instability or nerve compression

• Spinal stenosis (central, lateral recess, or foraminal) with neurogenic claudication unresponsive to epidural steroid injections and physiotherapy

• Adolescent idiopathic scoliosis (Cobb angle >45°) or adult degenerative scoliosis with documented progression or functional impairment

• Vertebral fracture (traumatic or osteoporotic, AO/OTA Type B or C) with neurological compromise or progressive deformity

• Post-laminectomy or post-discectomy instability (failed back surgery syndrome with identifiable structural cause)

• Spinal tumours (primary or metastatic) requiring stabilisation after corpectomy

• Ankylosing spondylitis with severe kyphotic deformity amenable to osteotomy and fusion

REQUIRED PRE-OPERATIVE DIAGNOSTICS:

• MRI spine (affected region) with and without contrast — mandatory baseline

• CT scan spine (thin-cut, 1 mm slices) for bony anatomy, screw trajectory planning, and 3-D reconstruction

• Standing full-length (36-inch) EOS or digital spine radiograph for global sagittal and coronal balance assessment

• Nerve conduction study (NCS) and electromyography (EMG) if radiculopathy or myelopathy is clinically ambiguous

• Bone mineral density (DEXA scan) — mandatory for patients >55 years or those on long-term corticosteroids

• Pre-operative laboratory panel: CBC, metabolic panel (BMP), HbA1c (diabetes), coagulation profile (PT/INR, aPTT), group & screen

• Cardiac evaluation: 12-lead ECG; echocardiogram (ECHO) if ASA Class III or known cardiac disease

• Pulmonary function tests (PFTs) for patients with significant scoliosis (Cobb >70°) or known COPD

• Nutritional screening (albumin, pre-albumin) — malnutrition is an independent predictor of surgical site infection

RELATIVE AND ABSOLUTE CONTRAINDICATIONS:

• Active systemic infection or surgical site infection (absolute contraindication)

• Uncorrected severe coagulopathy or platelet count <50,000/µL

• Active or metastatic malignancy without adequate oncological control (relative)

• Severe osteoporosis (T-score < −3.5) without pre-operative optimisation with anabolic agents (teriparatide/romosozumab)

• Uncontrolled insulin-dependent diabetes (HbA1c >8.5%) — significantly elevated infection and non-union risk

• Severe peripheral vascular disease compromising wound healing

• Active nicotine use (smokers have 2–3× higher pseudarthrosis rates; cessation for minimum 6 weeks is strongly recommended)

• Morbid obesity (BMI >40) in the absence of a structured pre-habilitation programme

• Significant psychiatric comorbidity (untreated depression, catastrophising) — somatisation predicts poor patient-reported outcomes

OPEN POSTEROLATERAL FUSION (PLF) — THE CLASSICAL STANDARD:

Decade-proven technique involving midline posterior exposure, posterolateral bone grafting between transverse processes, and bilateral pedicle screw-rod instrumentation. Still appropriate for multi-level constructs, complex deformity correction, or revision surgery where wide exposure is necessary. Associated with higher blood loss (500–1,500 mL) and longer hospitalisation but provides excellent long-term fusion rates (85–95% at 2 years with autograft).

MINIMALLY INVASIVE SURGERY (MIS) APPROACHES — CURRENT GOLD STANDARD FOR SUITABLE ANATOMY:

• MIS-TLIF (Transforaminal Lumbar Interbody Fusion): Performed through two 2.5 cm paramedian incisions using tubular retractors (METRx, Depuy Synthes). Bilateral pedicle screws placed percutaneously under fluoroscopic or robotic guidance; a single PEEK (polyether ether ketone) or titanium interbody cage packed with graft material is inserted via the transforaminal corridor. Reduces paraspinal muscle damage, blood loss (mean 120–250 mL), and hospitalisation (2–4 days).

• XLIF/LLIF (Extreme/Lateral Lumbar Interbody Fusion): Retroperitoneal trans-psoas approach allowing placement of a wide-footprint interbody cage (capable of indirect neural decompression) without violating the posterior musculature. Particularly advantageous for multi-level lumbar degenerative disease and mild-to-moderate scoliosis correction (L1–L4; avoids L4–5 due to lumbar plexus anatomy).

• ALIF (Anterior Lumbar Interbody Fusion): Anterior retroperitoneal approach providing the largest disc space preparation and greatest surface area for fusion. Ideal for L5–S1 due to anatomical access; often combined with posterior percutaneous screw fixation (standalone ALIF or combined 360° fusion).

• ACDF (Anterior Cervical Discectomy and Fusion): Standard of care for one- or two-level cervical disc disease causing radiculopathy or myelopathy. Disc excision, decompression of the spinal cord and nerve root, and cage-and-plate fixation via a 3–4 cm anterior neck incision. Fusion rates >95% at 12 months for single-level procedures.

• Posterior Cervical Fusion (PCF) / Occipito-Cervical Fusion: Required for multi-level cervical myelopathy, rheumatoid atlanto-axial instability, or odontoid fractures.

ROBOTIC-ASSISTED SPINAL FUSION:

Systems including Medtronic Mazor X Stealth Edition (integrated with StealthStation O-arm navigation), Globus ExcelsiusGPS, and NuVasive Pulse allow pre-operative CT-based trajectory planning and robotic arm-guided screw insertion with accuracy rates of 98.3–99.1% (Grade A placement per Gertzbein-Robbins scale), compared to 90–94% for freehand fluoroscopy-guided placement. This translates to fewer revision surgeries, reduced neurological complications, and lower radiation exposure to the surgical team. Multiple JCI-accredited centres in India (Medanta, Apollo, Fortis, Kokilaben Dhirubhai Ambani Hospital) and UAE facilities (Cleveland Clinic Abu Dhabi, Medcare, American Hospital Dubai) operate these platforms.

BIOLOGIC AUGMENTATION FOR FUSION ENHANCEMENT:

• Autologous iliac crest bone graft (ICBG): Gold standard biological; harvest-site morbidity in 10–30% of cases.

• Demineralised bone matrix (DBM) and cancellous allograft: Reduce autograft harvest requirements.

• rhBMP-2 (Infuse, Medtronic): Evidence-based osteoinductive agent approved for single-level ALIF; off-label use with documented efficacy in MIS-TLIF. Associated with transient radiculitis and, in cervical application, potentially serious soft-tissue swelling (restricted off-label use).

• Concentrated bone marrow aspirate (CBMA) with stem cell enrichment: Emerging adjunct with promising preliminary fusion data.

• Synthetic ceramics (β-tricalcium phosphate, hydroxyapatite): Osteoconductive scaffolds used as graft extenders.

INTRAOPERATIVE NEUROMONITORING (IONM):

Continuous somatosensory evoked potentials (SSEPs), motor evoked potentials (MEPs), and electromyography (EMG) are standard of care for all deformity corrections and high-risk spinal constructs, providing real-time feedback on spinal cord and nerve root integrity.

DEFORMITY CORRECTION TECHNIQUES:

For scoliosis and severe kyphosis, surgeons employ Smith-Petersen osteotomy (SPO), pedicle subtraction osteotomy (PSO), or vertebral column resection (VCR) — progressively powerful correction tools with correspondingly higher technical complexity and blood loss, managed with cell salvage (Cell Saver) systems and acute normovolaemic haemodilution.

PHASE 1 — REMOTE PRE-OPERATIVE ASSESSMENT (WEEKS 1–4 BEFORE TRAVEL):

• GAF Healthcare coordinates upload of all existing imaging (MRI, CT in DICOM format) and medical records to the chosen spine specialist for virtual case review.

• Treating spine surgeon issues a formal operative plan with technique, instrumentation, expected fusion levels, and cost estimate.

• Anaesthesiology pre-assessment via video teleconsult; cardiology or pulmonology clearance obtained if indicated.

• Patient completes smoking cessation (minimum 6 weeks prior), optimises HbA1c (<7.5% preferred), and begins pre-habilitation (core stabilisation physiotherapy to improve post-operative rehabilitation potential).

• Nutritional optimisation: protein intake >1.2 g/kg/day; vitamin D and calcium supplementation if deficient.

• GAF Healthcare processes e-Medical Visa application (India) or coordinates entry visa/visa-on-arrival (UAE).

PHASE 2 — ARRIVAL AND IMMEDIATE PRE-OPERATIVE PERIOD (DAY −1 TO DAY 0):

• Airport pickup by GAF Healthcare dedicated vehicle; check-in to hospital-affiliated accommodation or hospital itself.

• Pre-operative admissions workup: repeat blood panel, cross-match, ECG, anaesthesia assessment, consent process.

• Spine surgeon confirms final surgical plan using CT-based robotic trajectory planning software (if robotic-assisted).

• Pre-operative physiotherapy session: breathing exercises, post-operative movement coaching.

• Anaesthesia briefing; enhanced recovery after surgery (ERAS) protocol initiated — carbohydrate loading up to 2 hours pre-operatively (clear carbohydrate drinks), prophylactic analgesia (celecoxib, gabapentin, acetaminophen), and anti-emetics.

PHASE 3 — SURGERY DAY (DAY 0):

• General or combined regional-general anaesthesia with intraoperative neuromonitoring (SSEP, MEP, EMG).

• Duration: 2–3 hours (single-level MIS-TLIF or ACDF) to 5–8 hours (multi-level deformity correction with osteotomy).

• Intraoperative cell salvage (Cell Saver) routinely used; tranexamic acid (TXA) administered to reduce blood loss.

• Post-operatively, patient recovers in the surgical ICU or high-dependency unit (HDU) for 12–24 hours; neurological checks every 30 minutes in the first 6 hours.

PHASE 4 — INPATIENT RECOVERY (DAYS 1–6):

• Day 1: Patient mobilised to sitting and, in most MIS cases, standing and taking a few steps with physiotherapy assistance. Foley catheter removed. Pain managed with a multimodal protocol (IV ketorolac, oral acetaminophen, low-dose opioids only as required, and wound-local ropivacaine infusion catheters where applicable).

• Days 2–3: Progressive ambulation with walking frame; wound assessment; oral nutrition fully established; deep vein thrombosis (DVT) prophylaxis with low-molecular-weight heparin (LMWH, e.g., enoxaparin) and compression stockings.

• Days 4–5: Stair climbing assessment; brace fitting (if lumbar fusion — thoracolumbar orthosis/TLSO) or cervical collar (if ACDF); bowel function confirmed.

• Day 6–7: Surgical wound review; discharge criteria met (independent ambulation on flat surface, pain controlled on oral analgesia, no fever, stable wound).

PHASE 5 — OUT-OF-HOSPITAL RECOVERY IN COUNTRY (WEEKS 2–6):

• Patient stays in GAF Healthcare partner accommodation (serviced apartment or hotel) near the hospital.

• Outpatient physiotherapy sessions 3–5× per week: gait training, gentle core activation, scar mobilisation.

• Surgeon review at 2 weeks: wound inspection, suture/staple removal, post-operative X-ray to confirm hardware position.

• Fit-to-fly assessment at 4 weeks (short-haul, <4 hours): confirmed if pain controlled on oral analgesia, no DVT symptoms, independently ambulant, wound fully healed.

• Long-haul flights (>6 hours): generally cleared at 6–8 weeks; must travel in business/premium economy with aisle seat, perform in-seat ankle exercises every 30 minutes, and maintain LMWH prophylaxis for 24 hours post-flight.

PHASE 6 — HOME COUNTRY REHABILITATION (MONTHS 2–12):

• Month 2–3: Structured outpatient spinal physiotherapy; transition from walking frame to unassisted gait.

• Month 3–6: Core strengthening programme (McKenzie method, Pilates-based spinal rehabilitation); hydrotherapy often added.

• Month 6: Repeat MRI or CT to assess early osseointegration; surgeon teleconsult with GAF Healthcare coordination.

• Month 9–12: Progressive return to vocational activities; final fusion assessment (ideally CT demonstrating bridging trabecular bone across fused segments).

• Return to sedentary/desk work: 4–8 weeks. Manual labour: 4–6 months. Unrestricted physical activity: 9–12 months.